With over twenty years of pharmaceutical and biotechnological experience, Dr. JeanMarie Guenot is a giant in her field. With a taste for repairing companies, she has developed a passion for making a difference in the world. Currently, Guenot is the CEO and President of Amphivena Therapeutics, Inc., but in the past she has worked in many different types of companies in many different specific areas of study.
These include Corporate developments as well as Commercial, private as well as public, management in project and alliance, pharmaceutical R&D, as well as venture capital. With an impressive extent of expertise in her back pocket, Guenot’s current business venture is brought up around the goal of treating and curing hematologic malignancies through the development of unique multi-functional antibody therapies.
Before all her wild success and esteem, Guenot worked with therapeutics, dry AMD, ocular inflammation, macular degeneration, and sustained release ocular drug delivery technologies to help treat and cure glaucoma when she built SKS Ocular from the ground up as well as being a business adviser for the Hoffman-La Roche and the VP of Corporate and Business Development at PDL BioPharma.
With focused experience in cardiovascular diseases, oncology, neurology, autoimmune diseases, and ophthalmic diseases she has been able to do great things for the betterment of society as a whole with her extensive research and development projects.
Dr. JeanMarie Guenot has grown into an inspired force of creative intellect over the years. From building biology based companies and managing venture capital investments for Atlas Ventures in the beginning of her career in business and the start of a science career in the Pre-clinical R&D at the Hoffman-La Roche company, it is awesome to see how she was able to mesh both areas of study and interest to create her own company where she is now in the forefront of saving massive numbers of people from every day suffering thanks to her immense level and extent of research. It is an extremely inspiring eye opener to see such a brilliant woman take charge of the future of humanity in such a brave and bold way.